Beauty Health (NASDAQ:SKIN) Shares Up 5.4%

The Beauty Health Company (NASDAQ:SKIN) traded up 5.4% during mid-day trading on Tuesday . The stock traded as high as $4.35 and last traded at $4.33. 143,832 shares changed hands during trading, a decline of 95% from the average session volume of 2,901,702 shares. The stock had previously closed at $4.11.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on SKIN shares. Stifel Nicolaus reissued a “hold” rating and issued a $4.00 price objective (up from $3.00) on shares of Beauty Health in a report on Wednesday, March 13th. DA Davidson reissued a “buy” rating and issued a $5.00 price target on shares of Beauty Health in a research note on Friday, March 15th. Canaccord Genuity Group lifted their price objective on shares of Beauty Health from $3.00 to $4.00 and gave the company a “hold” rating in a research note on Thursday, March 14th. Piper Sandler reaffirmed an “underweight” rating and issued a $3.00 price objective (up previously from $2.00) on shares of Beauty Health in a report on Wednesday, March 13th. Finally, TD Cowen raised their target price on shares of Beauty Health from $2.50 to $4.00 and gave the company a “market perform” rating in a research note on Wednesday, March 13th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Beauty Health presently has an average rating of “Hold” and an average target price of $6.50.

Beauty Health Stock Up 4.1 %

The company has a current ratio of 6.07, a quick ratio of 5.28 and a debt-to-equity ratio of 12.43. The stock’s fifty day moving average is $3.33 and its two-hundred day moving average is $3.75.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings data on Tuesday, March 12th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.04. The business had revenue of $96.80 million during the quarter, compared to analyst estimates of $87.22 million. Beauty Health had a negative return on equity of 18.85% and a negative net margin of 25.65%. The company’s revenue was down 1.3% compared to the same quarter last year. During the same period last year, the company posted $0.03 EPS. As a group, sell-side analysts anticipate that The Beauty Health Company will post -0.12 EPS for the current year.

Institutional Trading of Beauty Health

A number of hedge funds have recently bought and sold shares of SKIN. Sierra Summit Advisors LLC acquired a new stake in shares of Beauty Health during the fourth quarter valued at approximately $856,000. Price T Rowe Associates Inc. MD grew its position in Beauty Health by 38.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 69,347 shares of the company’s stock worth $216,000 after purchasing an additional 19,150 shares in the last quarter. Barclays PLC grew its position in Beauty Health by 48.0% during the 4th quarter. Barclays PLC now owns 139,507 shares of the company’s stock worth $433,000 after purchasing an additional 45,220 shares in the last quarter. Numerai GP LLC acquired a new stake in Beauty Health during the 4th quarter valued at $567,000. Finally, Occudo Quantitative Strategies LP purchased a new stake in shares of Beauty Health in the fourth quarter valued at $217,000. 93.26% of the stock is owned by hedge funds and other institutional investors.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.